Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apollo Endosurgery was a gastrointestinal and bariatric medical device company focused on minimally invasive endoluminal surgery and endobariatric procedures. Its commercial portfolio included the OverStitch and OverStitch Sx endoscopic suturing systems, the X-Tack endoscopic helix tacking system, and the ORBERA intragastric balloon for weight management. The company developed and commercialized device-based alternatives to more invasive GI and bariatric surgery, serving physicians performing therapeutic endoscopy and obesity interventions. Apollo Endosurgery was acquired by Boston Scientific in April 2023 and now operates as part of Boston Scientific's endoscopy business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apollo Endosurgery.